New Clues About How Diabetes Damages Nerve Fibers—and Why Some Survive

Nerve damage in the hands and feet—called peripheral sensory neuropathy—is one of the most common and disabling complications of diabetes. People with this condition experience pain, numbness, and tingling that can make everyday activities difficult. Yet doctors have few effective treatments to offer. Many existing pain medications don't work well for diabetic nerve pain, and others come with significant side effects that make them impractical for long-term use.

To find better solutions, researchers need to understand exactly what happens to nerve fibers when diabetes develops. A new study used laboratory models of Type 1 and Type 2 diabetes to investigate this process in detail.

Scientists used two approaches: they induced Type 1 diabetes in rodents using a chemical, and they created Type 2 diabetes by feeding rodents high-fat diets. Both models developed pain sensitivity—they reacted more strongly to touch and temperature than healthy animals.

When researchers examined skin samples from the rodents' feet under a microscope, they found that overall nerve fiber density had decreased, confirming that diabetes does cause nerve degeneration. However, the findings revealed something unexpected: not all nerve fibers were equally affected. Pain-sensing nerve fibers (called nociceptor intraepidermal nerve fibers) actually persisted better than other types of sensory fibers. This differential survival suggests that different nerve fiber types have different vulnerabilities to diabetes's harmful effects.

This discovery—that some nerve fibers are more resilient than others—challenges the assumption that diabetic nerve damage is uniform. By understanding which fibers survive and why, researchers may be able to design treatments that specifically target the fibers that are most vulnerable or that contribute most to pain.

The findings underscore how much remains unknown about the precise mechanisms driving diabetic nerve pain. Closing these knowledge gaps is essential for developing new pain management strategies that actually work and don't burden patients with harmful side effects.

Source: Journal of diabetes research. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.